GlassScriptPhysician profile
Heather M Milea
NPI 1104348796
$1,863.64
in general payments reported to CMS, 2019-2025
19 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $230 · 2022: $167 · 2023: $343 · 2024: $769 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $290.89 | 2023-2024 | Epclusa |
| Lilly USA, LLC | $208.96 | 2023-2024 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $185.44 | 2022-2025 | Rexulti |
| Pfizer INC. | $148.52 | 2022-2025 | |
| Abbvie INC. | $145.37 | 2023-2025 | |
| Astellas Pharma US INC | $143.19 | 2024-2025 | Veozah |
| Regeneron Pharmaceuticals, INC. | $116.58 | 2021 | |
| Dexcom, INC. | $113.65 | 2021 | |
| Glaxosmithkline, LLC. | $102.88 | 2024-2025 | Shingrix |
| Avion Pharmaceuticals | $90.34 | 2023 | Dhivy |
| Lundbeck LLC | $88.38 | 2024-2025 | Rexulti |
| Neurelis, INC. | $58.80 | 2024 | Valtoco |
| Amneal Pharmaceuticals LLC | $36.77 | 2022-2023 | Rytary |
| Axsome Therapeutics, INC. | $32.00 | 2024 | Auvelity |
| Amgen INC. | $28.75 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $24.36 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.28 | 2024 | |
| Exact Sciences Corporation | $16.74 | 2023 | Cologuard Collection Kit |
| Acadia Pharmaceuticals INC | $14.74 | 2025 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Milea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.